Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
COMBAT Tincture is a clinically formulated, full-spectrum cannabis leaf (Vijaya) extract tincture developed by BOHECO (Bombay Hemp Company) for advanced pain management and palliative care. The formulation contains approximately 90 mg of major cannabinoids per ml in a 1:2 ratio of CBD (30 mg/ml) to THC (60 mg/ml), along with Curcuma longa (turmeric) rhizome extract and hemp seed oil. It is designed to interact with the body's endocannabinoid system by modulating cannabinoid receptors CB1 and CB2. COMBAT Tincture is marketed under medical supervision for the management of severe chronic pain, neuropathic pain, multiple sclerosis-associated symptoms, and palliative care symptoms such as nausea, appetite loss, and sleep disruption.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on COMBAT Tincture.